Platelet Membrane Nanocarriers Cascade Targeting Delivery System to Improve Myocardial Remodeling Post Myocardial Ischemia–Reperfusion Injury
Schematic illustration of PL720 cascade targeted therapy for MI/R in mice. When PL720 is administered at ischemia‐ reperfusion phase, it effectively targets the site of injury. Upon reaching the lesion site, the encapsulated L‐arginine is released to facilitate the production of NO for timely vasodilation. Simultaneously, the slow‐released FTY720 within the injured myocardium activates the AKT pathway in cardiomyocytes to alleviate cardiomyocyte apoptosis. When administered at the late perfusion inflammation phase, the PL720 captured monocyte (monocyte‐PL720 aggregates) is recruited to the heart lesion. Recruited monocytes in the heart differentiate into macrophages, and subsequently, the macrophages phagocytize PL720. With the sustained release of FTY720, the STAT3 signaling pathway of macrophages is activated, thereby promoting macrophage polarization. This process reduces sprouting vessel degeneration caused by long M1 subtype macrophages while increasing M2 subtype macrophages to promote the maturation and quiescence of sprouting vessels.
Publication
Platelet Membrane Nanocarriers Cascade Targeting Delivery System to Improve Myocardial Remodeling Post Myocardial Ischemia–Reperfusion Injury. (2024) Xuan Xu, et al. Adv Sci (Weinh). 2024 Apr;11(16):2308727. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Fast | FAST | ncbigene_synonym | FASTK | 10922 |
| Homo sapiens | Primates | Fast | FAST | ncbigene_synonym | FOXD3-AS1 | 100996301 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | TNF | TNF | ncbigene_symbol | TNF | 7124 |
| Homo sapiens | Primates | Arg-1 | ARG1 | ncbigene_symbol | ARG1 | 383 |
| Homo sapiens | Primates | Arg-1 | ARG1 | ncbigene_synonym | TINAGL1 | 64129 |
| Homo sapiens | Primates | NOS | NOS | ncbigene_synonym | NOS1 | 4842 |
| Homo sapiens | Primates | NOS | NOS | ncbigene_synonym | NOS2 | 4843 |
| Homo sapiens | Primates | NOS | NOS | famplex_relations | NOS3 | 4846 |
| Homo sapiens | Primates | IL-19 | IL19 | ncbigene_symbol | IL19 | 29949 |
| Homo sapiens | Primates | IL-10 | IL-10 | ncbigene_synonym | IL10 | 3586 |
| Homo sapiens | Primates | IL-12 | IL12 | famplex_relations | IL12A | 3592 |
| Homo sapiens | Primates | IL-12 | IL12 | famplex_relations | IL12B | 3593 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| L-arginine | L-arginine | (2S)-2-azaniumyl-5-{[azaniumyl(imino)methyl]amino}pentanoate | chebi:32682 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| ischemia | ischemia | ischemia | DOID:326 |